Bariatric Surgery | Medical XPRT
News
-
GI Dynamics Announces Final Data from the ENDO Trial, a Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity.
Initial results show the duodenal jejunal bypass liner (DJBL) technology met overall glycemic control efficacy and SAE related device removal safety endpoints Findings Presented at DDW 2022 BOSTON – June 15, 2022 – GI Dynamics, a ...
Ezisurg Medical presented at the European Bariatric Endoscopic Surgery Congress
ReShape Lifesciences Announces 2017 Weight Loss Contest Winner
ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
Equipment & Solutions
-
Showcase
Balloon System
The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight-loss surgeries are not eligible. The most common side effects reported were mild abdominal pain and nausea which typically resolved within two weeks. You must take daily ...
